• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Staats Ryan Edward claimed ownership of 40 shares (SEC Form 3)

    5/12/25 4:00:53 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care
    Get the next $DYNT alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Staats Ryan Edward

    (Last) (First) (Middle)
    2185 FOREST OAK DRIVE

    (Street)
    AKRON OH 44312

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    05/09/2025
    3. Issuer Name and Ticker or Trading Symbol
    DYNATRONICS CORP [ DYNT ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Operating Officer
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 40 D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    /s/ Ryan Edward Staats 05/12/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DYNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DYNT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DYNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      2/14/23 12:35:29 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      2/13/23 12:33:51 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      1/14/22 12:22:28 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    $DYNT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

      Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

      1/8/24 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Appointment of Dr. Christopher von Jako as new CEO

      Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

      6/21/23 9:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

      Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

      5/18/23 8:05:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    $DYNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $DYNT
    SEC Filings

    See more
    • New insider Staats Ryan Edward claimed ownership of 40 shares (SEC Form 3)

      3 - DYNATRONICS CORP (0000720875) (Issuer)

      5/12/25 4:00:53 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Director Enright Erin S. acquired 739,014 shares (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      4/3/25 3:12:03 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Large owner Provco Ventures 1 Lp acquired 369,292 shares, increasing direct ownership by 29% to 1,633,439 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      4/3/25 3:10:57 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by Dynatronics Corporation

      10-Q - DYNATRONICS CORP (0000720875) (Filer)

      5/12/25 4:00:27 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation filed SEC Form 8-K: Leadership Update

      8-K - DYNATRONICS CORP (0000720875) (Filer)

      5/9/25 8:00:26 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation filed SEC Form 8-K: Leadership Update

      8-K - DYNATRONICS CORP (0000720875) (Filer)

      4/18/25 7:30:18 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    $DYNT
    Leadership Updates

    Live Leadership Updates

    See more
    • Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

      Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

      1/8/24 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Appointment of Dr. Christopher von Jako as new CEO

      Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

      6/21/23 9:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

      Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

      5/18/23 8:05:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    $DYNT
    Financials

    Live finance-specific insights

    See more
    • Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

      Eagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:Competitive acquisitions by a significant rehabilitation customer; Reduction in specific SKUs of an OEM customer for the

      5/11/23 7:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

      Eagan, Minnesota--(Newsfile Corp. - April 27, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its third quarter of fiscal year 2023 on Thursday, May 11, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, May 11, 2023, to review its third quarter results.Interested persons may access the live conference call by dialing 1-800-319-4610 (U.S./Canada calle

      4/27/23 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

      EAGAN, MN / ACCESSWIRE / February 9, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.CEO Commentary"The year-over-year improvement in gross margin of 8.4% or nearly $1.0 million in gross profit was a solid improvement. We are pleased with our progression, but we have more work to do. New, targeted, and innovative, product releases are the third pillar of our gross margin improvement plan, and we plan to continue to improve our performance in

      2/9/23 7:30:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care